Effect of eptifibatide on platelet glycoprotein GPIIb/IIIa receptor blockade measured with the rapid platelet function assay
Hours after eptifibatide infusion . | Placebo period, %* . | Desmopressin period, %* . |
|---|---|---|
| 0 | 95 ± 1 (93-100) | 94 ± 1 (92-97) |
| 0.5 | 90 ± 2 (80-97) | 90 ± 2 (83-95) |
| 1.0 | 81 ± 2 (73-90) | 87 ± 1 (83-91) |
| 1.5 | 82 ± 1 (80-83) | 85 ± 1 (82-90) |
| 2.0 | 77 ± 2 (73-80) | 78 ± 3 (72-88) |
Hours after eptifibatide infusion . | Placebo period, %* . | Desmopressin period, %* . |
|---|---|---|
| 0 | 95 ± 1 (93-100) | 94 ± 1 (92-97) |
| 0.5 | 90 ± 2 (80-97) | 90 ± 2 (83-95) |
| 1.0 | 81 ± 2 (73-90) | 87 ± 1 (83-91) |
| 1.5 | 82 ± 1 (80-83) | 85 ± 1 (82-90) |
| 2.0 | 77 ± 2 (73-80) | 78 ± 3 (72-88) |
Values are expressed as mean ± SEM, with the range in parentheses.